http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101205289-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2005-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101205289-B1 |
| titleOfInvention | Improved Adjuvant Therapy of VII-250 Expressing Tumors |
| abstract | The present invention relates to a method of treating G250-antigen-expressing tumors, in particular renal clear cell cancer, comprising administering a G250-antigen-specific antibody to a high-risk patient diagnosed with a non-metastatic disease.n n n Adjuvant Therapy, Antibody, Renal Clear Cell Cancer, G250-Antigen, Nephrectomy |
| priorityDate | 2004-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 115.